Advertisement

Topics

AstraZeneca to withdraw European marketing authorisation application for cediranib

06:51 EDT 23 Sep 2016 | PharmaBiz

AstraZeneca announced its decision to withdraw the Marketing Authorisation Application (MAA) submitted to the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in June 2015

Original Article: AstraZeneca to withdraw European marketing authorisation application for cediranib

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca to withdraw European marketing authorisation application for cediranib"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...